Medicines Co. (MDCO) Tops Q4 EPS Views

Medicines Co. (NASDAQ: MDCO) reported Q4 EPS of ($0.88), $0.66 better than the analyst estimate of ($1.54). Revenue for the quarter came in at $67.2 million versus the consensus estimate of $64.11 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c